Trump Administration Reclassified Medical Marijuana to Schedule III
Initially, the Trump administration announced plans to reclassify marijuana from Schedule I to Schedule III, aiming to ease restrictions on medical research and taxation. This move was intended to acknowledge the medical benefits of marijuana and reduce regulatory hurdles for state-licensed medical marijuana.
Subsequently, the Justice Department officially reclassified state-licensed medical marijuana to Schedule III. This change recognized its medical use and lowered regulatory barriers, marking a significant shift in federal drug policy under the Trump administration in the United States.